Cite
Zuckermann A, Ploner M, Keziban U, et al. Benefit of mycophenolate-mofetil (MMF) in patients with cyclosporine (CYA) induced nephropathy after cardiac transplantation. J Heart Lung Transplant. 2001;20(2):163doi: 10.1016/s1053-2498(00)00296-5.
Zuckermann, A., Ploner, M., Keziban, U., Czerny, M., Wolner, E., Laufer, G., & Grimm, M. (2001). Benefit of mycophenolate-mofetil (MMF) in patients with cyclosporine (CYA) induced nephropathy after cardiac transplantation. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 20(2), 163. https://doi.org/10.1016/s1053-2498(00)00296-5
Zuckermann, A, et al. "Benefit of mycophenolate-mofetil (MMF) in patients with cyclosporine (CYA) induced nephropathy after cardiac transplantation." The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation vol. 20,2 (2001): 163. doi: https://doi.org/10.1016/s1053-2498(00)00296-5
Zuckermann A, Ploner M, Keziban U, Czerny M, Wolner E, Laufer G, Grimm M. Benefit of mycophenolate-mofetil (MMF) in patients with cyclosporine (CYA) induced nephropathy after cardiac transplantation. J Heart Lung Transplant. 2001 Feb;20(2):163. doi: 10.1016/s1053-2498(00)00296-5. PMID: 11250246.
Copy
Download .nbib
